Company
Rain Oncology Inc. (0001724979)
Standardized SEC financial data for Rain Oncology Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001724979 · Pharmaceutical Preparations.
Return on equity
-67.0%
Free cash flow
-$63.2M
Current ratio
6.08×
EPS (diluted)
$-2.71
Income statement
| USD | FY2020 | FY2021 | FY2022 |
|---|---|---|---|
| R&D expense | $15.4M | $40.8M | $61.4M |
| SG&A expense | $3.6M | $10.7M | $15.7M |
| Operating income | -$19.0M |
Balance sheet
| USD | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|
| Cash & equivalents | — | $58.9M | $24.8M | $62.0M |
| Total current assets | — | $59.5M | $146.1M | $133.6M |
Cash flow
| USD | FY2020 | FY2021 | FY2022 |
|---|---|---|---|
| Operating cash flow | -$11.2M | -$37.5M | -$63.2M |
| Capital expenditures | $24K | $128K | $8K |
| Free cash flow | -$11.3M | -$37.6M |
Get 0001724979 data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/0001724979/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/0001724979/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"